Equisolon

RSS

Prednisolone

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European Public Assessment Report. Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 02/04/2019

Authorisation details

Product details
Name
Equisolon
Agency product number
EMEA/V/C/002382
Active substance
Prednisolone
International non-proprietary name (INN) or common name
Prednisolone
Species
Horses
Anatomical therapeutic chemical veterinary (ATCvet) codes
QH02AB06
Publication details
Marketing-authorisation holder
LE VET B.V.
Revision
4
Date of issue of marketing authorisation valid throughout the European Union
12/03/2014
Contact address
Wilgenweg 7
3421 TV Oudewater
Netherlands

Product information

05/02/2019 Equisolon - EMEA/V/C/002382 - R/0004

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Systemic hormonal preparations
  • excl. sex hormones and insulin corticosteroids for systemic use corticosteroids for systemic use
  • plain glucocorticoids prednisolone

Therapeutic indication

Alleviation of inflammatory and clinical parameters associated with recurrent airway obstruction (RAO) in horses, in combination with environmental control.

Assessment history

How useful was this page?

Add your rating